Raphas Co., Ltd. (KOSDAQ:214260)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,750
+460 (4.47%)
At close: Mar 6, 2026
-32.01%
Market Cap 90.39B
Revenue (ttm) 32.16B
Net Income (ttm) 647.72M
Shares Out 8.41M
EPS (ttm) 75.61
PE Ratio 142.18
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 40,394
Average Volume 45,821
Open 10,350
Previous Close 10,290
Day's Range 10,190 - 10,750
52-Week Range 9,120 - 21,500
Beta 0.90
RSI 41.47
Earnings Date Mar 16, 2026

About Raphas

Raphas Co., Ltd. manufactures and sells biodegradable microneedles in Korea. The company offers skin care, medical device, whitening care, and wrinkle care under the Acropass brand; and health food product under the FitKong brand. It also supplies double-layer microneedle manufacturing technology; and provides original development manufacturing, and contract development and manufacturing organization services. The company was incorporated in 2006 and is based in Seoul, South Korea. [Read more]

Industry Perfumes, Cosmetics, and Other Toilet Preparations
Founded 2006
Employees 79
Stock Exchange KOSDAQ
Ticker Symbol 214260
Full Company Profile

Financial Performance

In 2024, Raphas's revenue was 27.22 billion, a decrease of -2.58% compared to the previous year's 27.94 billion. Losses were -4.77 billion, -45.80% less than in 2023.

Financial Statements

News

There is no news available yet.